End-of-Life Preferences, Length-of-Life Conversations, and Hospice Enrollment in Palliative Care: A Direct Observation Cohort Study among People with Advanced Cancer.


Journal

Journal of palliative medicine
ISSN: 1557-7740
Titre abrégé: J Palliat Med
Pays: United States
ID NLM: 9808462

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 12 12 2018
medline: 17 6 2020
entrez: 12 12 2018
Statut: ppublish

Résumé

Prognosis communication is one hypothesized mechanism by which effective palliative care (PC) promotes preference-concordant treatment near end of life (EOL), but little is known about this relationship. This is a multisite cohort study of 231 hospitalized patients with advanced cancer who consulted with PC. We audio-recorded the initial consultation with the PC team and coded conversations for all statements regarding expectations for how long the patient will live. We refer to these statements as length-of-life talk. We followed patients for up to six months to determine EOL treatment utilization, including hospice enrollment. Patients completed a brief interviewer-facilitated questionnaire at study enrollment. Forty-four percent (101/231) of observed conversations contained at least one statement about expectations for length of life, and 60% of patients (139/231) enrolled in hospice during the six months following these conversations. The association between length-of-life talk and hospice enrollment was strong among those (155/231) who endorsed treatment preferences favoring comfort over longevity in the last weeks to months of life (odds ratio [OR] Talking about expectations for remaining length of life during PC consultations is associated with six-month hospice enrollment among people with advanced cancer who endorse preferences for EOL treatment that favor comfort over longevity.

Identifiants

pubmed: 30526222
doi: 10.1089/jpm.2018.0476
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152-156

Auteurs

Robert Gramling (R)

1 Department of Family Medicine, Division of Palliative Medicine, University of Vermont Medical Center, Burlington, Vermont.

Luke T Ingersoll (LT)

2 Department of Consumer Science, Purdue University, West Lafayette, Indiana.

Wendy Anderson (W)

3 Department of Medicine, University of California, San Francisco, San Francisco, California.

Jeff Priest (J)

4 Medical Biostatistics Unit, University of Vermont, Burlington, Vermont.

Stephen Berns (S)

5 Department of Family Medicine, University of Vermont, Burlington, Vermont.

Katharine Cheung (K)

6 Department of Medicine, University of Vermont, Burlington, Vermont.

Sally A Norton (SA)

7 School of Nursing, University of Rochester, Rochester, New York.

Stewart C Alexander (SC)

2 Department of Consumer Science, Purdue University, West Lafayette, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH